In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Young Researchers Awards

During ESC Congress, the Working Group on Pulmonary Circulation and Right Ventricular Function holds its General Assembly to present achieved and upcoming activities to its members.

This is also the opportunity to award 4 to 6 young researchers (under 36) who submitted the best abstracts on Pulmonary Hypertension/Circulation and the best abstracts on Pulmonary Embolism.

Abstracts ranking is based on the marks awarded by the ESC abstract reviewers and by the Working Group leadership.

Awardees 2017

Irene Lang, Stephan Rosenkranz, Stefano Barco, Tatsuo Aoki, Karl-Patrik Kresoja, Taijyu Satoh, Barbara Girerd [left to right]

Awardees 2016

Stavros Konstantinides,  Sabina Rosset, Kenzo Ichimura, Max-Paul Winter,  Mona Sahlholdt Hansen, Irene Lang [left to right]









Awardees 2015

Stavros Konstantinides, Mario Gerges, Irene Lang,  Erik Klok, Kasper Hasseriis Andersen, Hideya Shigyo [left to the right]









Awardees  2014

4 Pulmonary Hypertension Awards (Unrestricted grant provided by Pfizer Limited):


2 Venous Thromboembolism Awards:


Awardees  2013

2 Venous Thromboembolism Awards:

Delphine Baudouy: B blood type is a strong risk factor for venous thromboembolism recurrence
Mareike Lankeit: Angiopoietin-2 - a novel biomarker for risk stratification of acute pulmonary embolism

2 Pulmonary Hypertension Awards:

Max-Paul Winter: Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Jose Manuel Montero Cabezas: Demythologizing pulmonary artery aneurysm: prevalence and associated complications in a large pulmonary arterial hypertension population

Awardees  2012

Abstract: Plasma MR-proADM is superior to NT-proBNP for all-cause short term mortality prediction in acute pulmonary embolismby Justyna Pedowska-Wloszek
Abstract: Pulmonary embolism in Sweden, a national cohort and survival analysis, by Therese Anderson
Abstract: Right ventricular hypertrophy and failure abolish cardioprotection by ischemic preconditioning, by Asger Andersen
Abstract: Survival in pre-capillary pulmonary hypertension: does echocardiography make the difference?, by Julia Grapsa
Abstract: Egr-1 expression is specific for neointimal development in both human and experimental PAH, by Michael Dickinson
Abstract: Treatment of decompensated left-sided heart failure lowers right ventricular pulsatile load and increases the pulmonary arterial time constant, by Matthias Dupont

Awardees  2011

Abstract: Pulmonary arterial stroke volume: a new and strong prognostic factor in pediatric pulmonary arterial hypertension
by Johannes Menno Douwes (NL)
Abstract: Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
by Barbara Girerd (FR)
Abstract: ESC-ERS 2009 pulmonary hypertension guidelines: an evaluation study in 9 European countries (the guide to PH study)
by Enri Leci (IT)
Abstract: Survival in patients with pulmonary arterial hypertension associated with connective tissue disease over the past decade
by Christopher Valerio (UK)
Abstract: Predictive value of the new highly sensitive troponin T assay compared to a clinical score in normotensive patients with acute pulmonary embolism: a prospective external validation study by Mareike Lankeit (DE)
Abstract: In-hospital major bleeding predicts mortality in patients with objectively confirmed pulmonary embolism
by Anna Budaj-Fidecka (PL)

Awardees  2010

Abstract: Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies, by Elena Beciani
Abstract: Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study, by Zhi-Cheng Jing